{"cmr":"ca-cm-kg/TSX/CSCI","node":"ca-cm-kg","as_of":"2026-11-06","version":1,"identity":{"name":{"value":"COSCIENS Biopharma Inc.","source_url":"https://www.tsx.com/json/company-directory/search/tsx/^*","read_by":"tsx.com company directory (exchange list)","state":"sourced"},"ticker":{"value":"CSCI","source_url":"https://www.tsx.com/json/company-directory/search/tsx/^*","read_by":"tsx.com company directory (exchange list)","state":"sourced"},"exchange":{"value":"TSX","source_url":"https://www.tsx.com/json/company-directory/search/tsx/^*","read_by":"tsx.com company directory (exchange list)","state":"sourced"},"security_type":{"value":"Corporate","source_url":"https://www.tsx.com/en/resource/571 (tsx-and-amp-tsxv-listed-companies-2026-08-14-en.xlsx, data as of 31-Jul-2026)","read_by":"TMX listed-companies workbook (exchange list, monthly; data month named in the source column)","state":"sourced"},"isin":{"value":"CA22112H1010","source_url":"https://stockanalysis.com/quote/tsx/CSCI/company","read_by":"adjudicated by Claude","state":"filled","second_source_url":"https://stockanalysis.com/quote/tsx/CSCI/company","second_read_by":"adjudicated by Claude"},"lei":{"value":null,"source_url":null,"read_by":null,"state":null,"reason":"no ISIN"},"sector":{"value":"Life Sciences","source_url":"https://www.tsx.com/en/resource/571 (tsx-and-amp-tsxv-listed-companies-2026-08-14-en.xlsx, data as of 31-Jul-2026)","read_by":"TMX listed-companies workbook (exchange list, monthly; data month named in the source column)","state":"sourced"},"jurisdiction":{"value":"Canada (federal, CBCA)","source_url":"https://www.stocktitan.net/sec-filings/CSCI/20-f-cosciens-biopharma-inc-files-annual-report-foreign-issuer-d894827f0f8f.html","read_by":"Tavily search + regex extraction from page text","state":"sourced"},"transfer_agent":{"value":"Computershare","source_url":"https://cosciensbio.com/investor-contacts","read_by":"Tavily search + regex extraction from page text","state":"sourced"},"auditor":{"value":"Deloitte LLP","source_url":"https://www.stocktitan.net/sec-filings/CSCI/20-f-cosciens-biopharma-inc-files-annual-report-foreign-issuer-d894827f0f8f.html","read_by":"Tavily regex","state":"sourced"},"newswire":{"value":"GlobeNewswire (1 release(s) seen)","source_url":"https://www.globenewswire.com/news-release/2025/11/14/3188655/0/en/COSCIENS-Biopharma-Inc-Announces-Leadership-Change.html","read_by":"Tavily search restricted to wire domains (release hits)","state":"confirmed","second_source_url":"Width 1 events: 7 of 7 releases on GlobeNewswire","second_read_by":"Width 1 12-month event set (independent observation)"},"hq_city":{"value":null,"source_url":null,"read_by":null,"state":null,"reason":"TMX workbook gives province/region only"},"hq_region":{"value":"QC","source_url":"https://www.tsx.com/en/resource/571 (tsx-and-amp-tsxv-listed-companies-2026-08-14-en.xlsx, data as of 31-Jul-2026)","read_by":"TMX listed-companies workbook (exchange list, monthly; data month named in the source column)","state":"sourced"},"tier":{"value":"n/a (single-tier market)","source_url":"https://www.tsx.com/json/company-directory/search/tsx/^*","read_by":"tsx.com company directory (exchange list)","state":"sourced"},"sedar_profile":{"value":null,"source_url":null,"read_by":null,"state":null,"reason":"no SEDAR+ profile matched name"},"sedi_link":{"value":"https://www.sedi.ca/sedi/SVTIIBIselectIssuer?locale=en_CA","source_url":null,"read_by":"constructed (SEDI insider-information-by-issuer search entry; no issuer number known) — UNVERIFIED: HTTP 403 on fetch","state":"unverified"}},"aliases":[],"events_url":"https://mcp.ca-cm-kg.ai/events/TSX/CSCI","event_count":9,"gaps":[{"field":"ISIN","reason":"ISIN conflict: CA22112H1010(2), CA22112H1192(2)"},{"field":"LEI","reason":"no ISIN"},{"field":"SEDAR+ profile link","reason":"no SEDAR+ profile matched name"},{"field":"SEDI link","reason":"unverified: sedi.ca returns HTTP 403 to automated clients"},{"field":"HQ city","reason":"TMX workbook gives province/region only"}],"halt":{"value":false,"source_url":"https://iiroc.mediaroom.com/index.php?s=2429&l=100","read_by":"CIRO Halts/Resumptions bulletins (iiroc.mediaroom.com)","read_at":"2026-11-08T09:32:00Z","state":"sourced"},"schema":"ECO-10060 v1.2 §7.1 · record schema v0.2 (unratified)","instrument_class":{"value":"Corporate Issuer","from":"TSX Listing Fee Schedule, B. Definitions (Corporate Issuer: issuer, including a special purpose acquisition corporation, other than a Closed-end Fund, Exchange Traded Product or Structured Product); D. Listing Fees Applicable to Corporate Issuers","source_url":"https://www.tsx.com/en/resource/1644","source_date":"Effective January 1, 2018","read_at":"2026-10-31T19:33:54Z","state":"sourced","basis":"rulebook","group":"tsx|Corporate"},"signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"PDhYTQzGAJMASQO1jz8YxJ4P5o6lFVKH1z12QtsDjiTSns5ezqlzKUMJQB5-inMkFdDPjNdxXX7lxcCwoN01BA","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}}